LBD
BMY icon

Landsberg Bennett & Dubbaneh’s Bristol-Myers Squibb BMY Stock Holding History

Landsberg Bennett & Dubbaneh’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-11,934
Closed -$751K – 267
2021
Q1 		$751K Buy
+11,934
New +$743K 0.11% 138
2020
Q4 		– Sell
-3,351
Closed -$201K – 227
2020
Q3 		$201K Buy
+3,351
New +$202K 0.04% 203

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Landsberg Bennett & Dubbaneh's BMY Position: Q2 2021 in Review

Landsberg Bennett & Dubbaneh sold out of Bristol-Myers Squibb (BMY) in Q2 2021, closing a stake of 11,934 shares — an estimated $751K sold.

Landsberg Bennett & Dubbaneh first reported a position in BMY in Q3 2020 and held it in 2 quarters. The position peaked at $751K in Q1 2021. 2,370 funds tracked by Wall St. Rank hold BMY as of Q2 2021.

  • Landsberg Bennett & Dubbaneh reported no remaining Bristol-Myers Squibb position as of Q2 2021 after selling out during the quarter.
  • Landsberg Bennett & Dubbaneh sold 11,934 Bristol-Myers Squibb shares in Q2 2021, an estimated $751K.
  • Landsberg Bennett & Dubbaneh first reported a position in Bristol-Myers Squibb in Q3 2020 and held it in 2 quarters.
  • Landsberg Bennett & Dubbaneh's Bristol-Myers Squibb position peaked at $751K in Q1 2021.
  • 2,370 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.

Based on Landsberg Bennett & Dubbaneh's 13F filing for Q2 2021, filed 29 Jul 2021.